Shree Ganesh Biotech India Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1.80 | 3.47 | 14.72 |
| Operating Expense | 1.47 | 4.42 | 13.94 |
| Net Profit | 0.33 | -0.95 | 0.77 |
| Net Profit Margin | 18.33 | -27.38 | 5.23 |
| Earning Per Share | 0.01 | -0.02 | 0.02 |
| EBIDTA | 0.33 | -0.95 | 0.77 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1.80 |
| Operating Expense | 1.47 |
| Net Profit | 0.33 |
| Net Profit Margin | 18.33 |
| Earning Per Share | 0.01 |
| EBIDTA | 0.33 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 22.96 | 20.28 | 62.45 |
| Operating Expenses Annual | 24.01 | 20.48 | 60.30 |
| Operating Profit Annual | 0.39 | 0.86 | 2.71 |
| Interest Annual | TBA | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 |
| Net Profit Annual | 0.28 | 0.62 | 2.04 |
| Tax Annual | 0.11 | 0.23 | 0.68 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 22.96 |
| Operating Expenses Annual | 24.01 |
| Operating Profit Annual | 0.39 |
| Interest Annual | TBA |
| Depreciation | 0.00 |
| Net Profit Annual | 0.28 |
| Tax Annual | 0.11 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.43 | 0.48 | 0.04 |
| Cash Flow from Operations | -10.21 | 10.16 | 10.54 |
| Cash Flow from Investing | 9.80 | -10.21 | -10.09 |
| Cash Flow from Financing | TBA | TBA | TBA |
| Cash Flow at the End | 0.01 | 0.43 | 0.48 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.43 |
| Cash Flow from Operations | -10.21 |
| Cash Flow from Investing | 9.80 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 1.70 | 4.24 | 4.34 |
| PBIT Margin (%) | 1.70 | 4.24 | 4.34 |
| PBT Margin (%) | 1.70 | 4.24 | 4.34 |
| Net PROFIT Margin (%) | 1.22 | 3.06 | 3.27 |
| Return On Networth / Equity (%) | 0.44 | 0.99 | 3.33 |
| Return On Networth /Employed (%) | 0.62 | 1.36 | 4.43 |
| Return On Assets (%) | 0.44 | 0.98 | 3.33 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.36 | 0.32 | 1.02 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 1.70 |
| PBIT Margin (%) | 1.70 |
| PBT Margin (%) | 1.70 |
| Net PROFIT Margin (%) | 1.22 |
| Return On Networth / Equity (%) | 0.44 |
| Return On Networth /Employed (%) | 0.62 |
| Return On Assets (%) | 0.44 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.00 | 0.00 | 0.00 |
| Total Current Assets Annual | 3.39 | 3.73 | 19.84 |
| Non Current Assets Annual | 60.09 | 69.89 | 59.68 |
| Total Shareholders Funds Annual | 63.26 | 62.98 | 62.36 |
| Total Assets Annual | 63.49 | 73.62 | 79.52 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.00 |
| Total Current Assets Annual | 3.39 |
| Non Current Assets Annual | 60.09 |
| Total Shareholders Funds Annual | 63.26 |
| Total Assets Annual | 63.49 |
No Data Availabe
